Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.783
+0.100 (14.72%)
At close: Feb 21, 2025, 4:00 PM
0.780
-0.003 (-0.33%)
After-hours: Feb 21, 2025, 7:53 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $13.22 million as of February 21, 2025. Its market cap has decreased by -69.80% in one year.
Market Cap
13.22M
Enterprise Value
7.46M
1-Year Change
-69.80%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $13.22M, a decrease of -76.91%. That is a compound annual growth rate of -32.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 13.22M | -3.86% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |